BUZZ-U.S. Stocks on the Move-Ambit, Athlon, Tonix, Tibco, Amag

Mon Sep 29, 2014 9:55am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s)

U.S. stocks opened lower on Monday, extending the previous week's decline as investors monitored the continued civil unrest in Hong Kong for any potential impact on Chinese growth. The Dow Jones industrial average was down 0.88 percent at 16,962.29 and the S&P 500 was down 0.85 percent at 1,965.94.

** AMBIT BIOSCIENCES CORP, $15.305, +86.65 pct

The drugmaker said Daiichi Sankyo Co Ltd will buy the company for $410 million, or $15 per share in cash. The company said the deal includes Ambit's lead blood cancer drug, quizartinib, which is currently in late-stage studies.

** TIBCO SOFTWARE INC, $23.585, +20.89 pct

The business software maker said buyout firm Vista Equity Partners had agreed to take it private for $4.3 billion.

  Continued...